Fever in Keppra - how severe and when it was recovered? (a real world drug study)

Summary:

We study how severe was Fever, when it was recovered, drug effectiveness, race, and more among people who take Keppra (levetiracetam). This phase IV clinical study is created by eHealthMe based on reports submitted to eHealthMe, and is updated regularly.

What is Keppra?

Keppra has active ingredients of levetiracetam. It is often used in epilepsy. eHealthMe is studying from 73,504 Keppra users. Check the latest studies of Keppra.

What is Fever?

Fever is found to be associated with 3,495 drugs and 6,198 conditions by eHealthMe. Check the latest studies of Fever.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Jul, 31, 2026

8 people who have Fever while taking Keppra were studied.

Severity of Fever *:

least: 16.67 %
moderate: 66.67 %
severe: 16.67 %
most severe: 0.0 %

When people recovered from Fever *:

while on drug: 0.0 %
after off the drug: 25 %
not yet: 75 %

Effectiveness of Keppra *:

not at all: 0.0 %
somewhat: 42.86 %
moderate: 28.57 %
high: 28.57 %
very high: 0.0 %

Race of the people *:

African American, Non-Hispanic: 0.0 %
American Indian/Alaska Native: 0.0 %
Asian: 25.0 %
Hispanic: 12.5 %
Native Hawaiians/Pacific Islanders: 12.5 %
Two or more races: 12.5 %
White, Non-Hispanic: 37.5 %

Time on Keppra *:

Gender of people when taking Keppra *:

female: 37.5 %
male: 62.5 %

Age of people when taking Keppra *:

Conditions people have *:

Sputum Abnormal: 1 person, 12.50%
Sleep Disorder: 1 person, 12.50%
Seizure Cluster (small group of seizure): 1 person, 12.50%
High Blood Pressure: 1 person, 12.50%
Generalized Anxiety Disorder (excessive, uncontrollable, unexplained and often irrational worry): 1 person, 12.50%
Constipation: 1 person, 12.50%
Abdominal Discomfort: 1 person, 12.50%

Other drugs people take besides Keppra *:

Other side effects people have besides Fever *:

Weakness: 1 person, 12.50%
Urine Potassium Decreased: 1 person, 12.50%
Nausea And Vomiting: 1 person, 12.50%
Mental Retardation (problems with learning and developing): 1 person, 12.50%
Leg Pain: 1 person, 12.50%
High-Pitched Crying: 1 person, 12.50%
Headache (pain in head): 1 person, 12.50%
Fatigue (feeling of tiredness): 1 person, 12.50%
Drowsiness: 1 person, 12.50%
Dizziness: 1 person, 12.50%

* Approximation only. Some reports may have incomplete information.

Do you take Keppra and have Fever?

Check whether Fever is associated with a drug or a condition

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related studies

Fever in Keppra

How the study uses the data?

The study is based on levetiracetam (the active ingredients of Keppra). Other drugs that have the same active ingredients (e.g. generic drugs) are considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.